The first Madrigal Pharmaceuticals trade was made in Q4 2017.
Since then Steven Cohen bought shares nine more times and sold shares on fourteen occasions. The investor completely sold their stake between Q2 2024 and Q3 2024.
Avg closing price
Price range
Sold -41 Thousand shares
Q3 2024
Avg closing price
$255.94
Price range
$212.22
-
$292.96
Sold 56.2% shares (-52.6 Thousand shares)
Q2 2024
Avg closing price
$238.04
Price range
$193.33
-
$291.99
New holding (+93.6 Thousand shares)
Q1 2024
Avg closing price
$235.62
Price range
$171.37
-
$283.23
Sold -173 Thousand shares
Q4 2023
Avg closing price
$174.99
Price range
$120.40
-
$237.13
New holding (+173 Thousand shares)
Q3 2023
Avg closing price
$188.22
Price range
$146.04
-
$225.78
Sold -3.99 Thousand shares
Q2 2023
Avg closing price
$270.85
Price range
$203.88
-
$312.00
New holding (+3.99 Thousand shares)
Q1 2023
Avg closing price
$272.48
Price range
$231.06
-
$307.08
Sold -22.9 Thousand shares
Q4 2022
Avg closing price
$95.59
Price range
$58.39
-
$296.54
New holding (+22.9 Thousand shares)
Q3 2022
Avg closing price
$69.48
Price range
$60.57
-
$79.51
Sold -30.1 Thousand shares
Q4 2021
Avg closing price
$82.16
Price range
$72.34
-
$95.09
New holding (+30.1 Thousand shares)
Q3 2021
Avg closing price
$86.38
Price range
$78.35
-
$105.02
Sold -78.9 Thousand shares
Q2 2020
Avg closing price
$98.34
Price range
$60.13
-
$125.71
New holding (+78.9 Thousand shares)
Q1 2020
Avg closing price
$83.31
Price range
$66.76
-
$93.49
Sold -30.5 Thousand shares
Q4 2019
Avg closing price
$96.98
Price range
$84.28
-
$118.50
Sold 47.3% shares (-27.4 Thousand shares)
Q3 2019
Avg closing price
$93.82
Price range
$84.40
-
$106.53
Increased shares by 178.8% (+37.1 Thousand shares)
Q2 2019